Chronic Disease Management Market - 2022-2031
The Chronic Disease Management Market was valued at US$ 4.8 billion in 2022 and is anticipated to reach US$ 14.6 billion by 2031, at a CAGR of 0.114 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Chronic Disease Management Market.
This report delivers a comprehensive overview of the Chronic Disease Management Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Chronic Disease Management Market. The Chronic Disease Management Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–2031.
Chronic Disease Management Market Scope:
By Type
This report delivers a comprehensive overview of the Chronic Disease Management Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Chronic Disease Management Market. The Chronic Disease Management Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–2031.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Chronic Disease Management Market.
This report delivers a comprehensive overview of the Chronic Disease Management Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Chronic Disease Management Market. The Chronic Disease Management Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–2031.
Chronic Disease Management Market Scope:
By Type
- Solution
- Services
- Consulting Services
- Educational Service
- Implementation Service
- Others
- On-Premise Solution
- Cloud-Based Solution
- Web-Based
- Cardiovascular Diseases (CVD)
- Diabetes
- Chronic Obstructive Pulmonary Disorders (COPD)
- Arthritis
- Asthma
- Cancer
- Others
- Healthcare Providers
- Healthcare Payers
- Others
- Allscripts Healthcare Solutions Inc.
- TriZetto Corporation
- Siemens Healthcare Private Limited
- IBM
- Pegasystems Inc.
- Koninklijke Philips NV
- EXL Healthcare
- Infosys Limited
- ScienceSoft USA Corporation
- ZeOmega
This report delivers a comprehensive overview of the Chronic Disease Management Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Chronic Disease Management Market. The Chronic Disease Management Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–2031.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Increase Your Customer Base by 3X using our Partner Identification tool
- Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
- Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
- Prioritize partners by strategic fit rather than general capability.
- Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
- Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
- White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
- Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
- Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
- Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Type
3.2. Snippet by Service Type
3.3. Snippet by Delivery Mode
3.4. Snippet by Indication
3.5. Snippet by Application
3.6. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Technological advancements
4.1.1.2. Active Major Players in Chronic Disease Management Solutions
4.1.1.3. Collaboration Among Major Players to Develop Advanced Solution
4.1.1.4. Digital Therapeutics Play an Important Role in Chronic-Disease Management
4.1.2. Restraints
4.1.2.1. High Costs for Designing and Implementation of Chronic Disease Management Platform
4.1.2.2. Patient Engagement Challenges
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 ANALYSIS
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Solution*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Services
8. BY SERVICE TYPE
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
8.1.2. Market Attractiveness Index, By Service Type
8.2. Consulting Services*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Educational Service
8.4. Implementation Service
8.5. Others
9. BY DELIVERY MODE
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
9.1.2. Market Attractiveness Index, By Delivery Mode
9.2. On-Premise Solution*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Cloud-Based Solution
9.4. Web-Based
10. BY INDICATION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.1.2. Market Attractiveness Index, By Indication
10.2. Cardiovascular Diseases (CVD)*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Diabetes
10.4. Chronic Obstructive Pulmonary Disorders (COPD)
10.5. Arthritis
10.6. Asthma
10.7. Cancer
10.8. Others
11. BY END-USER
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
11.1.2. Market Attractiveness Index, By End-user
11.2. Healthcare Providers*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Healthcare Payers
11.4. Others
12. BY REGION
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. UK
12.3.8.3. France
12.3.8.4. Italy
12.3.8.5. Spain
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. Australia
12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
13. COMPETITIVE LANDSCAPE
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. COMPANY PROFILES
14.1. Allscripts Healthcare Solutions Inc.*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. TriZetto Corporation
14.3. Siemens Healthcare Private Limited
14.4. IBM
14.5. Pegasystems Inc.
14.6. Koninklijke Philips NV
14.7. EXL Healthcare
14.8. Infosys Limited
14.9. ScienceSoft USA Corporation
14.10. ZeOmega (*LIST NOT EXHAUSTIVE)
15. APPENDIX
15.1. About Us and Services
15.2. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Snippet by Type
3.2. Snippet by Service Type
3.3. Snippet by Delivery Mode
3.4. Snippet by Indication
3.5. Snippet by Application
3.6. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Technological advancements
4.1.1.2. Active Major Players in Chronic Disease Management Solutions
4.1.1.3. Collaboration Among Major Players to Develop Advanced Solution
4.1.1.4. Digital Therapeutics Play an Important Role in Chronic-Disease Management
4.1.2. Restraints
4.1.2.1. High Costs for Designing and Implementation of Chronic Disease Management Platform
4.1.2.2. Patient Engagement Challenges
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 ANALYSIS
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Solution*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Services
8. BY SERVICE TYPE
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
8.1.2. Market Attractiveness Index, By Service Type
8.2. Consulting Services*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Educational Service
8.4. Implementation Service
8.5. Others
9. BY DELIVERY MODE
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
9.1.2. Market Attractiveness Index, By Delivery Mode
9.2. On-Premise Solution*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Cloud-Based Solution
9.4. Web-Based
10. BY INDICATION
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
10.1.2. Market Attractiveness Index, By Indication
10.2. Cardiovascular Diseases (CVD)*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Diabetes
10.4. Chronic Obstructive Pulmonary Disorders (COPD)
10.5. Arthritis
10.6. Asthma
10.7. Cancer
10.8. Others
11. BY END-USER
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
11.1.2. Market Attractiveness Index, By End-user
11.2. Healthcare Providers*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Healthcare Payers
11.4. Others
12. BY REGION
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. UK
12.3.8.3. France
12.3.8.4. Italy
12.3.8.5. Spain
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. Australia
12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Delivery Mode
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
13. COMPETITIVE LANDSCAPE
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. COMPANY PROFILES
14.1. Allscripts Healthcare Solutions Inc.*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. TriZetto Corporation
14.3. Siemens Healthcare Private Limited
14.4. IBM
14.5. Pegasystems Inc.
14.6. Koninklijke Philips NV
14.7. EXL Healthcare
14.8. Infosys Limited
14.9. ScienceSoft USA Corporation
14.10. ZeOmega (*LIST NOT EXHAUSTIVE)
15. APPENDIX
15.1. About Us and Services
15.2. Contact Us
